Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › Northern Cambria › NPI 1629089982
Physician

Vasil, John

Vasil, John was paid $2.69M by Medicaid between Sep 2020 and Dec 2024, across 44 billing codes. Its largest line is G9012, Other specified case management service not elsewhere classified — 56% of everything it billed.

33Billing provider infoVASIL, JOHN
NORTHERN CAMBRIA, PA 15714
33aNPI1629089982assigned 08/11/2006
28Total paid$2.69M
24GClaims42,985
24DCodes billed44
24AFirst – last monthSep 2020 – Dec 2024
Compared with peers

Next to other Family Medicine Physician providers in Pennsylvania

Rank by total paid#22 of 2,756
Median peer was paid$19K
This provider vs. median140×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K$150K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
20201,523$101K
20218,850$599K
20227,971$556K
20239,895$627K
2024incomplete14,746$805K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
G9012 Other specified case management service not elsewhere classified 56% 5,163 5,163 $1.51M
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 16% 8,018 6,962 $424K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 16% 11,388 9,009 $422K
95165 Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials 2.8% 945 390 $76K
G0396 Alcohol and/or substance (other than tobacco) misuse structured assessment (e.g., audit, dast), and brief intervention 15 to 30 minutes 2.6% 1,660 1,078 $71K
95004 Percutaneous tests with allergenic extracts, immediate type reaction 2.1% 298 298 $55K
G9008 Coordinated care fee, physician coordinated care oversight services 2.0% 311 311 $53K
80305 <1% 1,653 1,435 $18K
G0444 Annual depression screening, 5 to 15 minutes <1% 886 883 $10K
80061 Lipid panel <1% 771 767 $9K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 861 750 $9K
81002 <1% 1,156 1,084 $4K
32 more codes
90732 <1% 35 $4K
G0008 Administration of influenza virus vaccine <1% 364 $4K
82947 <1% 812 $3K
90661 <1% 100 $2K
90756 <1% 392 $2K
99204 Doctor's office visit, new patient (more involved) <1% 19 $1K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 163 $1K
83036 Hemoglobin; glycosylated (A1C) <1% 205 $1K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 42 $1K
99203 Doctor's office visit, new patient (routine) <1% 17 $1K
92551 <1% 158 $810.60
99173 <1% 157 $738.62
94060 <1% 34 $585.20
87400 <1% 85 $495.80
82962 <1% 272 $476.23
G0009 Administration of pneumococcal vaccine <1% 44 $440.00
85014 <1% 164 $422.66
85018 <1% 152 $390.71
94010 <1% 13 $198.00
90688 <1% 12 $132.00
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg <1% 172 $13.64
J7613 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg <1% 34 $1.19
3078F <1% 1,261 $0.01
3077F 0% 985 $0.00
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 0% 91 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 0% 148 $0.00
3074F 0% 1,073 $0.00
3080F 0% 505 $0.00
3075F 0% 756 $0.00
3079F 0% 1,451 $0.00
90686 0% 129 $0.00
3044F 0% 30 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.